Pant Projects an Expanding Role for Targeted Therapy in Pancreatic Cancer
Season 5, Episode 15, Jun 14, 2021, 06:55 PM
Dr. Pant discusses the current role for germline and somatic testing in pancreatic cancer, examines the research landscape with PARP inhibitors, KRAS inhibitors, and other targeted agents, and shares his hope for the future of drug development in the field.